Related Experiment Videos

[Infant mortality in a third level paediatric hospital. therapeutic effort limitation, clinical-pathological

E Alonso Villán1, J Pérez Rodríguez, J I Rodríguez

  • 1Servicio de Neonatología, Hospital Universitario La Paz, Madrid, Spain.

Insights

Infant and child mortality analysis in a pediatric hospital revealed prematurity and hematology oncology as leading causes of death. Autopsies provided valuable data, highlighting the importance of palliative care and accurate diagnoses in complex pediatric cases.

Area of Science:

  • Pediatric critical care medicine
  • Neonatal and perinatal medicine
  • Pediatric pathology

Context:

  • This study examines infant and child mortality within a specialized, third-level children's hospital.
  • The research focuses on a cohort of highly complex pediatric patients admitted between 2007 and 2009.
  • Analysis includes epidemiological data, autopsy findings, and diagnostic accuracy.

Purpose:

  • To analyze infant and child mortality patterns in a high-acuity pediatric hospital.
  • To evaluate the role of pediatric autopsies in identifying significant findings and discrepancies.
  • To assess the application of therapeutic effort limitation and palliative care in end-of-life pediatric cases.

Summary:

  • A total of 253 deaths were analyzed, with prematurity/low birth weight and hematology oncology malignancies being the primary causes.
  • Autopsies were performed in 53% of cases, yielding clinically significant findings in 7.8%, with one case showing potential for improved prognosis.
  • Therapeutic effort limitation and palliative care were utilized in 41.9% of cases, with death deemed expected in 83.9%.

Impact:

  • Hospital mortality reviews are crucial for assessing and improving the quality of pediatric care.
  • Pediatric autopsies remain a valuable tool for generating clinically significant data for healthcare providers and families.
  • The study underscores the increasing use of palliative care in pediatric end-of-life situations and the persistent challenge of achieving definitive etiological diagnoses in all cases.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...